AMAG Pharmaceuticals, Inc. (AMAG) saw a big move last session, as the company’s shares fell by more than 5% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for AMAG, as the stock is now down roughly 13% since Jan 15.
Although this slump was obviously disappointing, this biopharmaceutical company has seen a couple of positive revisions and its current year earnings consensus have moved higher over the past few weeks. This suggests that the recent slump might be a temporary blip on the radar for AMAG. So make sure to keep an eye on this stock going forward to see if yesterday’s price decline is confirmed by more weakness, or if it can rebound in the weeks ahead.
AMAG currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Better-ranked stocks in the same sector include Biogen Idec Inc. (BIIB), Cambrex Corporation. (CBM) and Coronado Biosciences, Inc. (CNDO). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment